| Elena Dolmatova, | |
|
3650 Steve Reynolds Blvd, Duluth, GA 30096-4506 | |
| (404) 365-0966 | |
| Not Available |
| Full Name | Elena Dolmatova |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 3650 Steve Reynolds Blvd, Duluth, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285029561 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 94031 (Georgia) | Primary |
| Entity Name | The Southeast Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245266956 PECOS PAC ID: 6204829013 Enrollment ID: O20040407000370 |
News Archive
In a story done by Kaiser Health News in collaboration with USA Today, KHN staff writer Phil Galewitz reports on a hospital in Tulsa, Okla. "An hour into knee replacement surgery — with U2's I Still Haven't Found What I'm Looking For playing in the background — Dr. Yogesh Mittal smiles as he raises the left leg of his patient, 76-year-old Frank Morrow.
MicroStockProfit.com announces an investment report featuring Sunesis Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A European consensus document aims to encourage interventionalists to choose radial artery over femoral artery access where possible when performing percutaneous coronary intervention.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C virus (HCV) effect. The product is currently in phase 2b clinical development for the treatment of hepatitis C. Debiopharm granted Novartis worldwide commercialisation rights to Debio 025 except for Japan.
A new, first-of-its-kind research study was announced today that will analyze how changes in diet and lifestyle can impact long-term wellness and contribute to healthy aging.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elena Dolmatova, 3650 Steve Reynolds Blvd, Duluth, GA 30096-4506 Ph: () - | Elena Dolmatova, 3650 Steve Reynolds Blvd, Duluth, GA 30096-4506 Ph: (404) 365-0966 |
News Archive
In a story done by Kaiser Health News in collaboration with USA Today, KHN staff writer Phil Galewitz reports on a hospital in Tulsa, Okla. "An hour into knee replacement surgery — with U2's I Still Haven't Found What I'm Looking For playing in the background — Dr. Yogesh Mittal smiles as he raises the left leg of his patient, 76-year-old Frank Morrow.
MicroStockProfit.com announces an investment report featuring Sunesis Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A European consensus document aims to encourage interventionalists to choose radial artery over femoral artery access where possible when performing percutaneous coronary intervention.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C virus (HCV) effect. The product is currently in phase 2b clinical development for the treatment of hepatitis C. Debiopharm granted Novartis worldwide commercialisation rights to Debio 025 except for Japan.
A new, first-of-its-kind research study was announced today that will analyze how changes in diet and lifestyle can impact long-term wellness and contribute to healthy aging.
› Verified 3 days ago
Dr. Yeohan Song, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3500 Mcclure Bridge Rd, Duluth, GA 30096 Phone: 770-476-3636 Fax: 770-476-5845 | |
Dr. Aneesh Gupta, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1012 Sugarloaf Reserve Dr, Duluth, GA 30097 Phone: 912-713-2378 | |
Martin C Ettinger, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3650 Steve Reynolds Blvd, Internal Medicine Health Care Team C, Duluth, GA 30096 Phone: 770-931-6012 | |
Nasima Ali, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3060 Creek Falls Way, Duluth, GA 30097 Phone: 404-789-9416 | |
Dr. Lewin Go Chuachiaco, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3650 Steve Reynolds Blvd, Dept Of Int Med Hctc Kaiser Permanente Medical Center A, Duluth, GA 30096 Phone: 770-931-6210 Fax: 770-931-6015 | |
Dr. Richard Reid Maxa, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3505 Duluth Park Ln, Building 4, Ste 400, Duluth, GA 30096 Phone: 678-597-3180 Fax: 678-597-3181 | |
Wendy Lin Warren, APRN NP-C Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4181 Pleasant Hill Rd Ste 150, Duluth, GA 30096 Phone: 470-292-3820 |